How often should you have your HbA1c measured?
There is no fixed testing frequency that applies to everyone: how often you have your HbA1c measured depends on your situation, but at least once a year is worthwhile if you have prediabetes or diabetes or are at risk. Discuss the right frequency with your GP or internist.
HbA1c is a measure of your average blood sugar over the past two to three months. A value between 5.7% and 6.4% indicates prediabetes, while a value of 6.5% or higher indicates diabetes. Prediabetes already noticeably raises the risk of cardiovascular disease, so measuring early makes sense.
How often you need to be tested depends on your situation. If you have diabetes and use insulin, your doctor will advise regular check-ups, often every three months. For well-managed type 2 diabetes without insulin, twice a year is generally sufficient, and more frequently if control is less stable. The claims in this overview do not concern an official guideline on testing frequency, but they do provide pointers: with prediabetes, at least one annual measurement is worthwhile to see whether you are progressing toward diabetes.
In addition to the classic laboratory test, continuous glucose monitors exist that track your blood sugar around the clock. People who wore such a monitor for more than 270 days per year saw their HbA1c drop by an average of more than 1.5 percentage points, compared with just over 0.6 percentage points without a monitor. A smaller study in 47 people with type 2 diabetes also saw improvements in weight, blood pressure and cholesterol. These are promising results, but the evidence is not yet watertight.
Finger-prick testing (self-monitoring at home) also helps, but the effect is modest: an average HbA1c reduction of 0.3 percentage points. The best result, a reduction of 0.35 percentage points, was achieved with 8 to 11 measurements per week, and only when the readings actually led to adjustments in diet, physical activity or medication. Measuring without acting on the results was of little value in the studies.
Finally: a continuous monitor can estimate your HbA1c reasonably well, but it does not yet replace a proper blood test. And in people with a hereditary elevated risk of pancreatic cancer, measuring HbA1c did not contribute to the early detection of that cancer, so it is not intended for that purpose.
The claims are drawn from observational studies, a small crossover study (n=47), a meta-analysis on self-monitoring and a CGM cohort. No direct guideline study on testing frequency is available in the source; the frequency recommendations are derived from the available claims.